New study aims to uncover how lung disease leads to pulmonary hypertension
NCT ID NCT07184671
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 30 times
Summary
This study will look at lung tissue, blood, and fluid samples from 105 adults having lung surgery to understand how pulmonary hypertension (high blood pressure in the lungs) develops in people with chronic lung disease. Participants are split into three groups: those with lung disease and pulmonary hypertension, those with lung disease but no hypertension, and those without either condition. The goal is to find early signs and possible targets for future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could identify biomarkers or targets for future treatments for pulmonary hypertension in chronic lung disease.
What could go wrong
This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.